Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Cardiologist ordered to pay $2.6M after foreign material left in patient’s femoral artery

The patient's leg remains disfigured years after the incident. 

EnCompass Technologies F2 embolic filter device TAVR embolic device

Interventional cardiologists perform world’s first TAVR with new embolic protection device

The device, designed with improved filtration and stability in mind, is now being investigated as part of a new pilot study. 

Regularly eating avocados is associated with a reduced risk of cardiovascular disease, according to a new study.

Plant-based diets—both vegetarian and vegan—linked to lower cholesterol levels, reduced risk of blocked arteries

A new systematic review and meta-analysis of 30 RCTs highlighted numerous benefits associated with vegetarian and vegan diets. Combining a plant-based diet with statin therapy, one researcher noted, could result "in an even larger beneficial effect.”

Thumbnail

Marijuana use linked to much higher risk of peripheral artery disease

New research presented at SCAI Scientific Sessions 2023 suggests that marijuana users should understand the early warning signs of PAD, including feelings of pain and coldness in the leg. 

Number of stroke deaths worldwide could reach nearly 5 million by 2030

The worldwide stroke rate has been decreasing over time, but the population is aging and growing at such a rapid rate that stroke-related mortality is still expected to rise. 

FDA grants fast track designation to Bayer’s new drug for preventing stroke in AFib patients

The new drug, asundexian, is currently the subject of two multicenter Phase III studies—the OCEANIC-AF trial and OCEANIC-STROKE trial—focused on its safety and efficacy.

M&A mergers and acquisitions business deal

Report: Medtronic, Johnson & Johnson consider Shockwave Medical acquisition after Boston Scientific talks stall

Shockwave Medical has already had a busy, successful 2023—what could be next for the IVL specialists?

Intravascular lithotripsy (IVL) Shockwave Medical PCI PAD CAD Disrupt PAD Disrupt CAD SCAI 2022

Boston Scientific’s deal to acquire Shockwave Medical reportedly hits a snag

Talks between the two companies have reached a standstill, according to a new report. The rumor appears to have impacted the stock prices of both Boston Scientific and Shockwave Medical. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.